Industry Research Reports
Part 1
Part 2
Part 3
Part 4
Part 5
Home > Reports > Medical Devices & Consumables > Global Congenital Heart Defect Closure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Congenital Heart Defect Closure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Description
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ 1226 million in 2025 to US$ 2173 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Congenital Heart Defect Closure Devices are advanced interventional medical devices designed for minimally invasive repair of structural heart abnormalities, including Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Ductus Arteriosus (PDA), and Patent Foramen Ovale (PFO). These devices are delivered via catheter to occlude abnormal openings within the heart, restoring normal hemodynamics and reducing the risk of heart failure and stroke. Typically composed of a nitinol mesh double-disc structure with polyester or PTFE membranes to promote tissue growth, they represent a shift from open-heart surgery toward catheter-based solutions. With advances in interventional imaging, bioresorbable materials, and delivery precision, such devices are becoming a cornerstone in congenital and structural heart disease therapy, offering strong clinical and commercial growth prospects.In 2024, global Congenital Heart Defect Closure Devices production reached approximately 388 k units, with an average global market price of around US$ 2900 perunit.The average gross profit margin of this product is 75%.
Congenital Heart Defect Closure Devices Market Size(US$)
M= millions and B=billions
The global improvement in cardiovascular care systems and higher screening rates for congenital heart disease are driving rapid growth in early diagnosis and minimally invasive treatment demand. Hospitals are shifting from open-heart surgery to catheter-based therapy, and closure devices are emerging as the preferred option due to their reduced trauma and faster recovery. Supportive public health policies, expanded reimbursement coverage, and the development of pediatric cardiac centers are further stimulating market expansion. Meanwhile, breakthroughs in bioresorbable materials and intelligent navigation technologies by leading manufacturers are accelerating product miniaturization and safety optimization, creating long-term innovation and substitution opportunities.
Despite its strong growth potential, the market faces lengthy approval cycles and stringent regulatory requirements, especially in the U.S. and Europe where long-term safety follow-up is mandated. Postoperative complications such as thrombosis, arrhythmia, and incomplete closure remain key clinical concerns. Manufacturing precision is another challenge, as nitinol purity and heat-treatment control directly affect device performance. In emerging markets, uneven hospital infrastructure and limited training capacity also restrict the adoption rate of closure devices.Hospitals and cardiac centers are increasingly adopting minimally invasive solutions, with adult PFO closure and personalized complex defect repairs becoming key growth segments. Clinicians now favor flexible, radiopaque, and bioresorbable devices offering long-term safety and imaging visibility. Pediatric cardiac care systems in China, India, and the Middle East are rapidly evolving, narrowing the technology gap between domestic and international brands and fostering a more diversified competitive landscape.High-purity nitinol alloy remains the core raw material, its superelasticity and shape-memory properties crucial for device reliability. The global production of premium nitinol wire is gradually shifting toward Asia, improving supply stability. Innovations in polyester, PTFE membranes, and bioresorbable polymers enhance biocompatibility and tissue integration. At the same time, stricter medical-grade certification and traceability requirements are pushing upstream suppliers toward higher purity standards, forming a key technological barrier in the closure device industry.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Congenital Heart Defect Closure Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Report Metric
Details
Report Title
Global Congenital Heart Defect Closure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
Forecasted Market Size in 2032
US$ 2173 million
CAGR(2026-2032)
8.6%
Market Size Available for Years
2026-2032
Global Congenital Heart Defect Closure Devices Companies Covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
HeartCare
Bairen Medical
Global Congenital Heart Defect Closure Devices Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Congenital Heart Defect Closure Devices Market, Segment by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Global Congenital Heart Defect Closure Devices Market, Segment by Application
Hospitals
Clinics
Others
Product Category
Double Disc Devices
Single Disc Devices
lug Type Devices
Market Segment
Nitinol
Stainless Steel
Other
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Defines the Congenital Heart Defect Closure Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Table of Contents
1 Study Coverage
1.1 Introduction to Congenital Heart Defect Closure Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Congenital Heart Defect Closure Devices Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 ASD Closure Devices
1.2.3 VSD Closure Devices
1.2.4 PDA Closure Devices
1.2.5 PFO Closure Devices
1.2.6 LAA Closure Devices
1.3 Market Segmentation by Device Structure
1.3.1 Global Congenital Heart Defect Closure Devices Market Size by Device Structure, 2021 vs 2025 vs 2032
1.3.2 Double Disc Devices
1.3.3 Single Disc Devices
1.3.4 lug Type Devices
1.4 Market Segmentation by Material
1.4.1 Global Congenital Heart Defect Closure Devices Market Size by Material, 2021 vs 2025 vs 2032
1.4.2 Nitinol
1.4.3 Stainless Steel
1.4.4 Other
1.5 Market Segmentation by Application
1.5.1 Global Congenital Heart Defect Closure Devices Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Congenital Heart Defect Closure Devices Revenue Estimates and Forecasts (2021-2032)
2.2 Global Congenital Heart Defect Closure Devices Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Congenital Heart Defect Closure Devices Sales Estimates and Forecasts (2021-2032)
2.4 Global Congenital Heart Defect Closure Devices Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Congenital Heart Defect Closure Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Congenital Heart Defect Closure Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 ASD Closure Devices: Market Share by Key Manufacturers
3.5.2 VSD Closure Devices: Market Share by Key Manufacturers
3.5.3 PDA Closure Devices: Market Share by Key Manufacturers
3.5.4 PFO Closure Devices: Market Share by Key Manufacturers
3.5.5 LAA Closure Devices: Market Share by Key Manufacturers
3.6 Global Congenital Heart Defect Closure Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Congenital Heart Defect Closure Devices Sales Performance by Type
4.1.1 Global Congenital Heart Defect Closure Devices Sales Volume by Type (2021-2032)
4.1.2 Global Congenital Heart Defect Closure Devices Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Congenital Heart Defect Closure Devices Sales Performance by Device Structure
4.2.1 Global Congenital Heart Defect Closure Devices Sales Volume by Device Structure (2021-2032)
4.2.2 Global Congenital Heart Defect Closure Devices Revenue by Device Structure (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Device Structure (2021-2032)
4.3 Global Congenital Heart Defect Closure Devices Sales Performance by Material
4.3.1 Global Congenital Heart Defect Closure Devices Sales Volume by Material (2021-2032)
4.3.2 Global Congenital Heart Defect Closure Devices Revenue by Material (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Material (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Congenital Heart Defect Closure Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Congenital Heart Defect Closure Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Congenital Heart Defect Closure Devices Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Congenital Heart Defect Closure Devices Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Congenital Heart Defect Closure Devices Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Congenital Heart Defect Closure Devices Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Congenital Heart Defect Closure Devices Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Congenital Heart Defect Closure Devices Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Congenital Heart Defect Closure Devices Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Congenital Heart Defect Closure Devices Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Congenital Heart Defect Closure Devices Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Congenital Heart Defect Closure Devices Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.1.4 Abbott Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Congenital Heart Defect Closure Devices Sales by Product in 2025
11.1.6 Abbott Congenital Heart Defect Closure Devices Sales by Application in 2025
11.1.7 Abbott Congenital Heart Defect Closure Devices Sales by Geographic Area in 2025
11.1.8 Abbott Congenital Heart Defect Closure Devices SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Boston Scientific Congenital Heart Defect Closure Devices Sales by Product in 2025
11.2.6 Boston Scientific Congenital Heart Defect Closure Devices Sales by Application in 2025
11.2.7 Boston Scientific Congenital Heart Defect Closure Devices Sales by Geographic Area in 2025
11.2.8 Boston Scientific Congenital Heart Defect Closure Devices SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 LifeTech
11.3.1 LifeTech Corporation Information
11.3.2 LifeTech Business Overview
11.3.3 LifeTech Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.3.4 LifeTech Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 LifeTech Congenital Heart Defect Closure Devices Sales by Product in 2025
11.3.6 LifeTech Congenital Heart Defect Closure Devices Sales by Application in 2025
11.3.7 LifeTech Congenital Heart Defect Closure Devices Sales by Geographic Area in 2025
11.3.8 LifeTech Congenital Heart Defect Closure Devices SWOT Analysis
11.3.9 LifeTech Recent Developments
11.4 Lepu Medical
11.4.1 Lepu Medical Corporation Information
11.4.2 Lepu Medical Business Overview
11.4.3 Lepu Medical Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.4.4 Lepu Medical Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Lepu Medical Congenital Heart Defect Closure Devices Sales by Product in 2025
11.4.6 Lepu Medical Congenital Heart Defect Closure Devices Sales by Application in 2025
11.4.7 Lepu Medical Congenital Heart Defect Closure Devices Sales by Geographic Area in 2025
11.4.8 Lepu Medical Congenital Heart Defect Closure Devices SWOT Analysis
11.4.9 Lepu Medical Recent Developments
11.5 Occlutech
11.5.1 Occlutech Corporation Information
11.5.2 Occlutech Business Overview
11.5.3 Occlutech Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.5.4 Occlutech Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Occlutech Congenital Heart Defect Closure Devices Sales by Product in 2025
11.5.6 Occlutech Congenital Heart Defect Closure Devices Sales by Application in 2025
11.5.7 Occlutech Congenital Heart Defect Closure Devices Sales by Geographic Area in 2025
11.5.8 Occlutech Congenital Heart Defect Closure Devices SWOT Analysis
11.5.9 Occlutech Recent Developments
11.6 W. L. Gore & Associates
11.6.1 W. L. Gore & Associates Corporation Information
11.6.2 W. L. Gore & Associates Business Overview
11.6.3 W. L. Gore & Associates Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.6.4 W. L. Gore & Associates Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 W. L. Gore & Associates Recent Developments
11.7 Starway
11.7.1 Starway Corporation Information
11.7.2 Starway Business Overview
11.7.3 Starway Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.7.4 Starway Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Starway Recent Developments
11.8 Coherex Medical
11.8.1 Coherex Medical Corporation Information
11.8.2 Coherex Medical Business Overview
11.8.3 Coherex Medical Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.8.4 Coherex Medical Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Coherex Medical Recent Developments
11.9 Cardia
11.9.1 Cardia Corporation Information
11.9.2 Cardia Business Overview
11.9.3 Cardia Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.9.4 Cardia Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Cardia Recent Developments
11.10 MicroPort
11.10.1 MicroPort Corporation Information
11.10.2 MicroPort Business Overview
11.10.3 MicroPort Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.10.4 MicroPort Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 MicroPort Recent Developments
11.11 HeartCare
11.11.1 HeartCare Corporation Information
11.11.2 HeartCare Business Overview
11.11.3 HeartCare Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.11.4 HeartCare Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 HeartCare Recent Developments
11.12 Bairen Medical
11.12.1 Bairen Medical Corporation Information
11.12.2 Bairen Medical Business Overview
11.12.3 Bairen Medical Congenital Heart Defect Closure Devices Product Models, Descriptions and Specifications
11.12.4 Bairen Medical Congenital Heart Defect Closure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Bairen Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Congenital Heart Defect Closure Devices Industry Chain
12.2 Congenital Heart Defect Closure Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Congenital Heart Defect Closure Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Congenital Heart Defect Closure Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Congenital Heart Defect Closure Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Congenital Heart Defect Closure Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Device Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Material, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Congenital Heart Defect Closure Devices Revenue by Region (US$ Million), 2021-2026
Table 7. Global Congenital Heart Defect Closure Devices Revenue by Region (US$ Million), 2027-2032
Table 8. Global Congenital Heart Defect Closure Devices Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Congenital Heart Defect Closure Devices Sales by Region (K Units), 2021-2026
Table 10. Global Congenital Heart Defect Closure Devices Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Congenital Heart Defect Closure Devices Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Congenital Heart Defect Closure Devices Sales Share by Manufacturers (2021-2026)
Table 14. Global Congenital Heart Defect Closure Devices Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Congenital Heart Defect Closure Devices Revenue, 2025
Table 18. Global Congenital Heart Defect Closure Devices Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Congenital Heart Defect Closure Devices Average Selling Price (ASP) by Manufacturers (USD/Unit), 2021-2026
Table 20. Key Manufacturers Congenital Heart Defect Closure Devices Manufacturing Base and Headquarters
Table 21. Global Congenital Heart Defect Closure Devices Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Congenital Heart Defect Closure Devices Sales Volume by Type (K Units), 2021-2026
Table 25. Global Congenital Heart Defect Closure Devices Sales Volume by Type (K Units), 2027-2032
Table 26. Global Congenital Heart Defect Closure Devices Revenue by Type (US$ Million), 2021-2026
Table 27. Global Congenital Heart Defect Closure Devices Revenue by Type (US$ Million), 2027-2032
Table 28. Global Congenital Heart Defect Closure Devices Sales Volume by Device Structure (K Units), 2021-2026
Table 29. Global Congenital Heart Defect Closure Devices Sales Volume by Device Structure (K Units), 2027-2032
Table 30. Global Congenital Heart Defect Closure Devices Revenue by Device Structure (US$ Million), 2021-2026
Table 31. Global Congenital Heart Defect Closure Devices Revenue by Device Structure (US$ Million), 2027-2032
Table 32. Global Congenital Heart Defect Closure Devices Sales Volume by Material (K Units), 2021-2026
Table 33. Global Congenital Heart Defect Closure Devices Sales Volume by Material (K Units), 2027-2032
Table 34. Global Congenital Heart Defect Closure Devices Revenue by Material (US$ Million), 2021-2026
Table 35. Global Congenital Heart Defect Closure Devices Revenue by Material (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Congenital Heart Defect Closure Devices Sales by Application (K Units), 2021-2026
Table 38. Global Congenital Heart Defect Closure Devices Sales by Application (K Units), 2027-2032
Table 39. Congenital Heart Defect Closure Devices High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Congenital Heart Defect Closure Devices Revenue by Application (US$ Million), 2021-2026
Table 41. Global Congenital Heart Defect Closure Devices Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Congenital Heart Defect Closure Devices Growth Accelerators and Market Barriers
Table 45. North America Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Congenital Heart Defect Closure Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Congenital Heart Defect Closure Devices Growth Accelerators and Market Barriers
Table 48. Europe Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Congenital Heart Defect Closure Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Congenital Heart Defect Closure Devices Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Congenital Heart Defect Closure Devices Growth Accelerators and Market Barriers
Table 53. Southeast Asia Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Congenital Heart Defect Closure Devices Investment Opportunities and Key Challenges
Table 55. Central and South America Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Congenital Heart Defect Closure Devices Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Congenital Heart Defect Closure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Major Businesses
Table 60. Abbott Product Models, Descriptions and Specifications
Table 61. Abbott Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 62. Abbott Sales Value Proportion by Product in 2025
Table 63. Abbott Sales Value Proportion by Application in 2025
Table 64. Abbott Sales Value Proportion by Geographic Area in 2025
Table 65. Abbott Congenital Heart Defect Closure Devices SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. Boston Scientific Corporation Information
Table 68. Boston Scientific Description and Major Businesses
Table 69. Boston Scientific Product Models, Descriptions and Specifications
Table 70. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 71. Boston Scientific Sales Value Proportion by Product in 2025
Table 72. Boston Scientific Sales Value Proportion by Application in 2025
Table 73. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 74. Boston Scientific Congenital Heart Defect Closure Devices SWOT Analysis
Table 75. Boston Scientific Recent Developments
Table 76. LifeTech Corporation Information
Table 77. LifeTech Description and Major Businesses
Table 78. LifeTech Product Models, Descriptions and Specifications
Table 79. LifeTech Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 80. LifeTech Sales Value Proportion by Product in 2025
Table 81. LifeTech Sales Value Proportion by Application in 2025
Table 82. LifeTech Sales Value Proportion by Geographic Area in 2025
Table 83. LifeTech Congenital Heart Defect Closure Devices SWOT Analysis
Table 84. LifeTech Recent Developments
Table 85. Lepu Medical Corporation Information
Table 86. Lepu Medical Description and Major Businesses
Table 87. Lepu Medical Product Models, Descriptions and Specifications
Table 88. Lepu Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Lepu Medical Sales Value Proportion by Product in 2025
Table 90. Lepu Medical Sales Value Proportion by Application in 2025
Table 91. Lepu Medical Sales Value Proportion by Geographic Area in 2025
Table 92. Lepu Medical Congenital Heart Defect Closure Devices SWOT Analysis
Table 93. Lepu Medical Recent Developments
Table 94. Occlutech Corporation Information
Table 95. Occlutech Description and Major Businesses
Table 96. Occlutech Product Models, Descriptions and Specifications
Table 97. Occlutech Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 98. Occlutech Sales Value Proportion by Product in 2025
Table 99. Occlutech Sales Value Proportion by Application in 2025
Table 100. Occlutech Sales Value Proportion by Geographic Area in 2025
Table 101. Occlutech Congenital Heart Defect Closure Devices SWOT Analysis
Table 102. Occlutech Recent Developments
Table 103. W. L. Gore & Associates Corporation Information
Table 104. W. L. Gore & Associates Description and Major Businesses
Table 105. W. L. Gore & Associates Product Models, Descriptions and Specifications
Table 106. W. L. Gore & Associates Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. W. L. Gore & Associates Recent Developments
Table 108. Starway Corporation Information
Table 109. Starway Description and Major Businesses
Table 110. Starway Product Models, Descriptions and Specifications
Table 111. Starway Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Starway Recent Developments
Table 113. Coherex Medical Corporation Information
Table 114. Coherex Medical Description and Major Businesses
Table 115. Coherex Medical Product Models, Descriptions and Specifications
Table 116. Coherex Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Coherex Medical Recent Developments
Table 118. Cardia Corporation Information
Table 119. Cardia Description and Major Businesses
Table 120. Cardia Product Models, Descriptions and Specifications
Table 121. Cardia Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. Cardia Recent Developments
Table 123. MicroPort Corporation Information
Table 124. MicroPort Description and Major Businesses
Table 125. MicroPort Product Models, Descriptions and Specifications
Table 126. MicroPort Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. MicroPort Recent Developments
Table 128. HeartCare Corporation Information
Table 129. HeartCare Description and Major Businesses
Table 130. HeartCare Product Models, Descriptions and Specifications
Table 131. HeartCare Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. HeartCare Recent Developments
Table 133. Bairen Medical Corporation Information
Table 134. Bairen Medical Description and Major Businesses
Table 135. Bairen Medical Product Models, Descriptions and Specifications
Table 136. Bairen Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. Bairen Medical Recent Developments
Table 138. Key Raw Materials Distribution
Table 139. Raw Materials Key Suppliers
Table 140. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 141. Milestones in Production Technology Evolution
Table 142. Distributors List
Table 143. Market Trends and Market Evolution
Table 144. Market Drivers and Opportunities
Table 145. Market Challenges, Risks, and Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Congenital Heart Defect Closure Devices Product Picture
Figure 2. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. ASD Closure Devices Product Picture
Figure 4. VSD Closure Devices Product Picture
Figure 5. PDA Closure Devices Product Picture
Figure 6. PFO Closure Devices Product Picture
Figure 7. LAA Closure Devices Product Picture
Figure 8. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Device Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Double Disc Devices Product Picture
Figure 10. Single Disc Devices Product Picture
Figure 11. lug Type Devices Product Picture
Figure 12. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Material, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Nitinol Product Picture
Figure 14. Stainless Steel Product Picture
Figure 15. Other Product Picture
Figure 16. Global Congenital Heart Defect Closure Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Hospitals
Figure 18. Clinics
Figure 19. Others
Figure 20. Congenital Heart Defect Closure Devices Report Years Considered
Figure 21. Global Congenital Heart Defect Closure Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 23. Global Congenital Heart Defect Closure Devices Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 24. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Region (2021-2032)
Figure 25. Global Congenital Heart Defect Closure Devices Sales (K Units), 2021-2032
Figure 26. Global Congenital Heart Defect Closure Devices Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 27. Global Congenital Heart Defect Closure Devices Sales Market Share by Region (2021-2032)
Figure 28. Top 5 and Top 10 Manufacturers Congenital Heart Defect Closure Devices Sales Volume Market Share in 2025
Figure 29. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share Ranking (2025)
Figure 30. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 31. ASD Closure Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 32. VSD Closure Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 33. PDA Closure Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 34. PFO Closure Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 35. LAA Closure Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Global Congenital Heart Defect Closure Devices Sales Volume-Based Market Share by Type (2021-2032)
Figure 37. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Type (2021-2032)
Figure 38. Global Congenital Heart Defect Closure Devices ASP by Type (USD/Unit), 2021-2032
Figure 39. Global Congenital Heart Defect Closure Devices Sales Volume-Based Market Share by Device Structure (2021-2032)
Figure 40. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Device Structure (2021-2032)
Figure 41. Global Congenital Heart Defect Closure Devices ASP by Device Structure (USD/Unit), 2021-2032
Figure 42. Global Congenital Heart Defect Closure Devices Sales Volume-Based Market Share by Material (2021-2032)
Figure 43. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Material (2021-2032)
Figure 44. Global Congenital Heart Defect Closure Devices ASP by Material (USD/Unit), 2021-2032
Figure 45. Global Congenital Heart Defect Closure Devices Sales Market Share by Application (2021-2032)
Figure 46. Global Congenital Heart Defect Closure Devices Revenue-Based Market Share by Application (2021-2032)
Figure 47. Global Congenital Heart Defect Closure Devices ASP by Application (USD/Unit), 2021-2032
Figure 48. North America Congenital Heart Defect Closure Devices Sales YoY (K Units), 2021-2032
Figure 49. North America Congenital Heart Defect Closure Devices Revenue YoY (US$ Million), 2021-2032
Figure 50. North America Top 5 Manufacturers Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) in 2025
Figure 51. North America Congenital Heart Defect Closure Devices Sales Volume (K Units) by Application (2021-2032)
Figure 52. North America Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 53. US Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 54. Canada Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 55. Mexico Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 56. Europe Congenital Heart Defect Closure Devices Sales YoY (K Units), 2021-2032
Figure 57. Europe Congenital Heart Defect Closure Devices Revenue YoY (US$ Million), 2021-2032
Figure 58. Europe Top 5 Manufacturers Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) in 2025
Figure 59. Europe Congenital Heart Defect Closure Devices Sales Volume (K Units) by Application (2021-2032)
Figure 60. Europe Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 61. Germany Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 62. France Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 63. U.K. Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 64. Italy Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 65. Russia Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 66. Asia-Pacific Congenital Heart Defect Closure Devices Sales YoY (K Units), 2021-2032
Figure 67. Asia-Pacific Congenital Heart Defect Closure Devices Revenue YoY (US$ Million), 2021-2032
Figure 68. Asia-Pacific Top 8 Manufacturers Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) in 2025
Figure 69. Asia-Pacific Congenital Heart Defect Closure Devices Sales Volume (K Units) by Application (2021-2032)
Figure 70. Asia-Pacific Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 71. Indonesia Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 72. Japan Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 73. South Korea Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 74. China Taiwan Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 75. India Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 76. Central and South America Congenital Heart Defect Closure Devices Sales YoY (K Units), 2021-2032
Figure 77. Central and South America Congenital Heart Defect Closure Devices Revenue YoY (US$ Million), 2021-2032
Figure 78. Central and South America Top 5 Manufacturers Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) in 2025
Figure 79. Central and South America Congenital Heart Defect Closure Devices Sales Volume (K Units) by Application (2021-2032)
Figure 80. Central and South America Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 81. Brazil Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 82. Argentina Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 83. Middle East, and Africa Congenital Heart Defect Closure Devices Sales YoY (K Units), 2021-2032
Figure 84. Middle East and Africa Congenital Heart Defect Closure Devices Revenue YoY (US$ Million), 2021-2032
Figure 85. Middle East and Africa Top 5 Manufacturers Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) in 2025
Figure 86. Middle East and Africa Congenital Heart Defect Closure Devices Sales Volume (K Units) by Application (2021-2032)
Figure 87. Middle East and Africa Congenital Heart Defect Closure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 88. GCC Countries Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 89. Turkey Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 90. Egypt Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 91. South Africa Congenital Heart Defect Closure Devices Revenue (US$ Million), 2021-2032
Figure 92. Congenital Heart Defect Closure Devices Industry Chain Mapping
Figure 93. Regional Congenital Heart Defect Closure Devices Manufacturing Base Distribution (%)
Figure 94. Global Congenital Heart Defect Closure Devices Production Market Share by Region (2021-2032)
Figure 95. Congenital Heart Defect Closure Devices Production Process
Figure 96. Regional Congenital Heart Defect Closure Devices Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives InterviewedDescription
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ 1226 million in 2025 to US$ 2173 million by 2032, at a CAGR of 8.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Congenital Heart Defect Closure Devices are advanced interventional medical devices designed for minimally invasive repair of structural heart abnormalities, including Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Ductus Arteriosus (PDA), and Patent Foramen Ovale (PFO). These devices are delivered via catheter to occlude abnormal openings within the heart, restoring normal hemodynamics and reducing the risk of heart failure and stroke. Typically composed of a nitinol mesh double-disc structure with polyester or PTFE membranes to promote tissue growth, they represent a shift from open-heart surgery toward catheter-based solutions. With advances in interventional imaging, bioresorbable materials, and delivery precision, such devices are becoming a cornerstone in congenital and structural heart disease therapy, offering strong clinical and commercial growth prospects.In 2024, global Congenital Heart Defect Closure Devices production reached approximately 388 k units, with an average global market price of around US$ 2900 perunit.The average gross profit margin of this product is 75%.
The global improvement in cardiovascular care systems and higher screening rates for congenital heart disease are driving rapid growth in early diagnosis and minimally invasive treatment demand. Hospitals are shifting from open-heart surgery to catheter-based therapy, and closure devices are emerging as the preferred option due to their reduced trauma and faster recovery. Supportive public health policies, expanded reimbursement coverage, and the development of pediatric cardiac centers are further stimulating market expansion. Meanwhile, breakthroughs in bioresorbable materials and intelligent navigation technologies by leading manufacturers are accelerating product miniaturization and safety optimization, creating long-term innovation and substitution opportunities.
Despite its strong growth potential, the market faces lengthy approval cycles and stringent regulatory requirements, especially in the U.S. and Europe where long-term safety follow-up is mandated. Postoperative complications such as thrombosis, arrhythmia, and incomplete closure remain key clinical concerns. Manufacturing precision is another challenge, as nitinol purity and heat-treatment control directly affect device performance. In emerging markets, uneven hospital infrastructure and limited training capacity also restrict the adoption rate of closure devices.Hospitals and cardiac centers are increasingly adopting minimally invasive solutions, with adult PFO closure and personalized complex defect repairs becoming key growth segments. Clinicians now favor flexible, radiopaque, and bioresorbable devices offering long-term safety and imaging visibility. Pediatric cardiac care systems in China, India, and the Middle East are rapidly evolving, narrowing the technology gap between domestic and international brands and fostering a more diversified competitive landscape.High-purity nitinol alloy remains the core raw material, its superelasticity and shape-memory properties crucial for device reliability. The global production of premium nitinol wire is gradually shifting toward Asia, improving supply stability. Innovations in polyester, PTFE membranes, and bioresorbable polymers enhance biocompatibility and tissue integration. At the same time, stricter medical-grade certification and traceability requirements are pushing upstream suppliers toward higher purity standards, forming a key technological barrier in the closure device industry.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Congenital Heart Defect Closure Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Chapter Outline
Chapter 1: Defines the Congenital Heart Defect Closure Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Related Reports
Global Congenital Heart Defect Closure Devices Market Research Report 2024
The global Congenital Heart Defect Closure Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 84
USD 2900.00
(Single User License)
Global Congenital Heart Defect Closure Devices Market Insights, Forecast to 2030
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 89
USD 4900.00
(Single User License)
Global Congenital Heart Defect Closure Devices Market Research Report 2025
The global market for Congenital Heart Defect Closure Devices was valued at US$ 1125 million in the year 2024 and is projected to reach a revised size of US$ 2016 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published: 2025-10-24
Pages: 89
USD 2900.00
(Single User License)
Congenital Heart Defect Closure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 103
USD 3950.00
(Single User License)
Global Congenital Heart Defect Closure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congenital Heart Defect Closure Devices market size was US$ 1125 million in 2024 and is forecast to a readjusted size of US$ 2016 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 98
USD 4250.00
(Single User License)
Global Congenital Heart Defect Closure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ 1125 million in 2024 to US$ 2016 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 155
USD 4900.00
(Single User License)
Congenital Heart Defect Closure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ 1125 million in 2024 and is forecast to a readjusted size of US$ 2016 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 111
USD 3950.00
(Single User License)
Global Congenital Heart Defect Closure Devices Market Research Report 2026
The global Congenital Heart Defect Closure Devices market was valued at US$ 1226 million in 2025 and is anticipated to reach US$ 2173 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 124
USD 2900.00
(Single User License)
Congenital Heart Defect Closure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ 1226 million in 2025 and is projected to reach US$ 2173 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 118
USD 3950.00
(Single User License)
Global Congenital Heart Defect Closure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Congenital Heart Defect Closure Devices market size was US$ 1226 million in 2025 and is forecast to reach a readjusted size of US$ 2173 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 95
USD 4250.00
(Single User License)
Global Congenital Heart Defect Closure Devices Market Research Report 2024
The global Congenital Heart Defect Closure Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 84
USD 2900.00 (Single User License)Global Congenital Heart Defect Closure Devices Market Insights, Forecast to 2030
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 89
USD 4900.00 (Single User License)Global Congenital Heart Defect Closure Devices Market Research Report 2025
The global market for Congenital Heart Defect Closure Devices was valued at US$ 1125 million in the year 2024 and is projected to reach a revised size of US$ 2016 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published: 2025-10-24
Pages: 89
USD 2900.00 (Single User License)Congenital Heart Defect Closure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 103
USD 3950.00 (Single User License)Global Congenital Heart Defect Closure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congenital Heart Defect Closure Devices market size was US$ 1125 million in 2024 and is forecast to a readjusted size of US$ 2016 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 98
USD 4250.00 (Single User License)Global Congenital Heart Defect Closure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congenital Heart Defect Closure Devices market is projected to grow from US$ 1125 million in 2024 to US$ 2016 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 155
USD 4900.00 (Single User License)Congenital Heart Defect Closure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ 1125 million in 2024 and is forecast to a readjusted size of US$ 2016 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 111
USD 3950.00 (Single User License)Global Congenital Heart Defect Closure Devices Market Research Report 2026
The global Congenital Heart Defect Closure Devices market was valued at US$ 1226 million in 2025 and is anticipated to reach US$ 2173 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 124
USD 2900.00 (Single User License)Congenital Heart Defect Closure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congenital Heart Defect Closure Devices was estimated to be worth US$ 1226 million in 2025 and is projected to reach US$ 2173 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 118
USD 3950.00 (Single User License)Global Congenital Heart Defect Closure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Congenital Heart Defect Closure Devices market size was US$ 1226 million in 2025 and is forecast to reach a readjusted size of US$ 2173 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
Have a question?
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database